Sulfur gets excreted through sweat, leading to unpleasant odors
the high-affinity ligand is a potent analgesic while the low-affinity ligand produces catalepsy in rats
A positive readout would allow submission of an NDA to the FDA, with approval possibly following in 2027 and commercial availability shortly after
The current GHK-Cu FDA approval status is mainly influenced by high drug development costs, limited clinical data, formulation stability challenges, and its established role as a GHK-Cu cosmetic ingredient
Clinicians utilizing these findings have developed targeted treatment protocols, often referred to as the "Brewer Protocol," which focus on eradicating fungal colonization in the sinus cavities using biofilm disruptors and intranasal antifungals
Deals Connected to Dosing Protocols Use the deal page to find a code, then use the protocol for vial math, reconstitution, storage, and research context